Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Novo Nordisk offers 3.1 billion dollars for Belgian biotech group Ablynx

      Novo Nordisk offers 3.1 billion dollars for Belgian biotech group Ablynx

      Ruby Khatun Khatun9 Jan 2018 10:00 AM IST
      BRUSSELS: Danish drugmaker Novo Nordisk said on Monday it had made a 2.6 billion euros ($3.12 billion) bid for Belgian biotech group Ablynx, the...
      Siemens to list Healthineers unit in March: sources

      Siemens to list Healthineers unit in March: sources

      Ruby Khatun Khatun9 Jan 2018 9:30 AM IST
      MUNICH: Siemens plans to list its 40 billion euro ($48 billion) healthcare unit Healthineers in March, two people close to the matter said, as the...
      Multi Crore Scam in X-ray Film Purchase: Kerala Govt Confirms Irregularities

      Multi Crore Scam in X-ray Film Purchase: Kerala Govt Confirms Irregularities

      Ruby Khatun Khatun8 Jan 2018 5:18 PM IST
      Kochi: Multi-crore irregularities have been confirmed by the state health authorities in the purchase of X-ray film for use in computerized...
      Patanjali plans massive online push

      Patanjali plans massive online push

      Ruby Khatun Khatun8 Jan 2018 10:45 AM IST
      New Delhi: Baba Ramdev-led Patanjali Ayurved is likely to partner with eight leading retailers and aggregators to give a big push to online sales of...
      No plans to revamp NPPA: Govt

      No plans to revamp NPPA: Govt

      Ruby Khatun Khatun8 Jan 2018 10:30 AM IST
      New Delhi: The government is not considering revamping the drug price regulator NPPA or setting up an advisory body above it, Parliament was...
      Pfizer ends research for new Alzheimers, Parkinsons drugs

      Pfizer ends research for new Alzheimer's, Parkinson's drugs

      Ruby Khatun Khatun8 Jan 2018 10:30 AM IST
      NEW YORK: Pfizer Inc is abandoning research to find new drugs aimed at treating Alzheimer’s and Parkinson’s disease, the U.S. pharmaceutical company...
      Five healthcare startups to watch out for in 2018

      Five healthcare startups to watch out for in 2018

      Ruby Khatun Khatun8 Jan 2018 10:15 AM IST
      New Delhi: Healthcare has become India's one of the largest sectors - both in terms of revenue and employment. Healthcare is an industry with the...
      Alphabet healthcare gets 20.8 million dollars funding to help Medicaid patients

      Alphabet healthcare gets 20.8 million dollars funding to help Medicaid patients

      Ruby Khatun Khatun8 Jan 2018 10:00 AM IST
      Cityblock Health, a healthcare company which aims to serve low-income urban residents covered by Medicaid and Medicare, said it received $20.8 million...
      FDA expands use of Amgens blockbuster drug

      FDA expands use of Amgen's blockbuster drug

      Ruby Khatun Khatun8 Jan 2018 9:45 AM IST
      Amgen Inc said that the U.S. Food and Drug Administration approved its drug, Xgeva, to prevent fractures in patients with multiple myeloma.Xgeva has...
      Mallinckrodt completes Stannsoporfin new drug application filing

      Mallinckrodt completes Stannsoporfin new drug application filing

      Ruby Khatun Khatun8 Jan 2018 9:30 AM IST
      Mallinckrodt plc announced it has successfully completed the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug...
      CCI slaps fine on two Gujarat chemists associations

      CCI slaps fine on two Gujarat chemists associations

      Ruby Khatun Khatun7 Jan 2018 12:30 PM IST
      New Delhi: Clamping down on unfair trade practices in the pharma business, the Competition Commission has imposed a total penalty of over Rs 12 lakh...
      40 complaints regarding stent overpricing received: Govt

      40 complaints regarding stent overpricing received: Govt

      Ruby Khatun Khatun7 Jan 2018 11:00 AM IST
      New Delhi: Drug pricing regulator NPPA has received a total of 40 complaints so far for overpricing of coronary stents by hospitals, Parliament was...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok